Invention Grant
- Patent Title: Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
-
Application No.: US16028662Application Date: 2018-07-06
-
Publication No.: US11136410B2Publication Date: 2021-10-05
- Inventor: Donald W. Kufe , Surender Kharbanda
- Applicant: DANA-FARBER CANCER INSTITUTE, INC. , GENUS ONCOLOGY, LLC
- Applicant Address: US MA Boston; US IL Chicago
- Assignee: DANA-FARBER CANCER INSTITUTE, INC.,GENUS ONCOLOGY, LLC
- Current Assignee: DANA-FARBER CANCER INSTITUTE, INC.,GENUS ONCOLOGY, LLC
- Current Assignee Address: US MA Boston; US IL Chicago
- Agency: Parker Highlander PLLC
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/30 ; A61K47/68 ; A61K38/08 ; A61K45/06 ; C07K16/28
Abstract:
The present invention is directed to antibodies binding to MUC1-C/extracellular domain (MUC1-C/ECD) and methods of using such antibodies to treat cancers that express the MUC1 antigen.
Public/Granted literature
- US20180312605A1 ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD) Public/Granted day:2018-11-01
Information query
